首页|基于我国WS/T促甲状腺激素受体抗体检测方法的性能验证

基于我国WS/T促甲状腺激素受体抗体检测方法的性能验证

扫码查看
目的 基于我国卫生行业标准(WS/T)对迈瑞高敏磁微粒化学发光法(CLIA)检测TRAb进行性能验证.方法 参照最新WS/T文件,以Roche Cobase 601电化学发光法(ECLIA)作为已验证的检测方法,对迈瑞CLIA的精密度、基于患者血清的正确度、线性、检出限、参考区间进行验证,评价迈瑞与Roche的诊断符合率.结果 迈瑞CLIA检测TRAb的批内CV为1.56%~4.60%,实验室内CV为1.65%~5.19%;与Roche ECLIA的实验室相对差值为-3.6%;在0.02~44.00IU/L范围内线性拟合方程Y=1.040X+0.636,线性系数R2=0.990;24个检出限临界值数据22个(91.7%)≤0.3IU/L;20个健康体检者血清TRAb检测结果仅1个超出参考区间≤1.9IU/L;与Roche ECLIA的诊断总符合率90%,阳性符合率75%,阴性符合率100%,Kappa检验值0.7826(P<0.001).结论 迈瑞高敏磁微粒CLIA的精密度、基于患者血清的正确度、线性范围、检出限均符合厂家声明,参考区间经验证可转移至我实验室使用,与Roche的诊断符合率较好,该方法性能能满足本医院临床检验需求.
An Analytical Performance Evaluation of Thyroid Stimulating Hormone Receptor Antibody(TRAb)Magnetic Particle Chemiluminescence Immunoassay According to Chinese WS/T Document
Objective The current study aims to evaluate the performance of the Mindray magnetic particle chemiluminescence immunoassay (CLIA ) for thyroid stimulating hormone receptor antibody (TRAb ) detection according to Chinese Health Industry Standard (WS/T)document.Methods A total of 50 serum samples were collected from the outpatients and healthy subjects of the Aerospace Central Hospital from April to June,2022.Roche electrochemiluminescence immunoassay (ECLIA)on Cobas e601 was claimed as the validation method by Mindray.The analytical performance of Mindray CLIA were assessed with within-run and inter-laboratory imprecision,relative difference based on patient samples,linearity,limit of detection,reference range,and the clinical agrrement with Roche ECLIA.Results The within-run and inter-laboratory imprecision of Mindray CLIA for TRAb detection ranged from 1.56% to 4.60% and 1.65% to 5.19%,respectively.The relative difference between Mindray CLIA and Roche ECLIA was -3.6%.CLIA showed a linear response ranging from 0.02 IU/L to 44.00 IU/L with a fitted equation:Y=1.040X+0.636 and a linear coefficient R2=0.990.Only two results from twnety four data points (2/24)close to functional assay sensitivity were out of the detection limit (0.3 IU/L).Among 20 serum samples from healthy subjects,only one result exceeded the reference range (≤1.9IU/L).The positive coincidence rate,negative coincidence rate and total coincidence rate of the two assays for detecting TRAb were 75%,100%,and 90%,respectively,and the Kappa value was 0.7826 (P<0.001).Conclusion The Mindray CLIA shows a decent precision and truness based on patient samples and linearity as manufacturer's claims.The valiated reference range can be transferred to our laboratory,and there is a good clinical agreement between the Mindray CLIA and the Roche ECLIA.CLIA can be used as a reliable method for clinical detection of serum TRAb levels in our laboratory.

Thyrotropin receptor antibodyHigh sensitivity magnetic particle chemiluminescence assayPerformance verificationClinical agreement

吴秀镯、齐天琪、曾洁、刘雪凯、刘艳娟

展开 >

航天中心医院检验科,北京 100049

北京医院国家老年医学中心/国家卫生健康委临床检验中心/中国医学科学院老年医学研究院,北京 100730

促甲状腺激素受体抗体 高敏磁微粒化学发光法 性能验证 符合率

北京市卫生健康委重点专科培育类项目(2021)

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(1)
  • 22